Target intelligence / Profile preview

Potato virus X coat protein (PVX CP) (PVX CP)

Target
PVX CP
Molecular classification
Viral protein, Vaccine carrier, Adjuvant, Virus-like particle (VLP) component
01

Overview

The Potato virus X coat protein (PVX CP) is a 25 kDa structural protein derived from a plant virus that has been repurposed as a potent immunostimulatory carrier for therapeutic vaccines (Lico et al., 2015; PubMed: 25613745). It naturally assembles into filamentous virus-like particles (VLPs), providing a robust scaffold for the multivalent display of fused or conjugated antigens, which significantly enhances their visibility to the immune system (McCormick et al., 2008; PubMed: 18599451). Beyond its role as a physical carrier, PVX CP acts as a molecular adjuvant by triggering innate immune signaling pathways that promote the maturation of dendritic cells and the subsequent activation of robust T-cell and B-cell responses (Savonne et al., 2016; PubMed: 27461114). This dual functionality makes it a valuable component in the development of vaccines for cancer, such as those targeting B-cell malignancies or HER2-positive tumors, as well as for infectious diseases (Uhde-Holzem et al., 2010; PubMed: 20624193). In clinical and preclinical settings, PVX CP-based fusions are designed to overcome immune tolerance to self-antigens or poorly immunogenic viral proteins (ClinicalTrials.gov, NCT00006012).

Other names
PVX CPCapsid protein of Potato virus XPVX coat protein fusion platformPotato virus X capsid protein
02

Mechanism of action

Acts as a high-density multivalent display platform for antigens and functions as a molecular adjuvant by stimulating innate immune pathways, likely through pattern recognition receptors (PRRs), to enhance T-cell and B-cell responses.

03

Biological functions

Immune responseAntigen presentationViral assemblyImmunostimulation
04

Disease associations

CancerInfection
05

Safety considerations

Anti-carrier immunogenicity (antibodies against PVX CP)Injection site inflammatory reactionsPotential for hypersensitivity to plant-derived proteinsSystemic cytokine release (theoretical)
06

Interacting drugs

PVX-Id vaccine (B-cell lymphoma idiotype)

3 more in the full profile.

07

Biomarkers

Anti-antigen antibody titers (IgG)Antigen-specific T-cell activation (IFN-gamma ELISpot)Dendritic cell maturation markers (CD80, CD86)Cytokine profiles (IL-12, TNF-alpha)

Beyond the preview

Go deeper on Potato virus X coat protein (PVX CP) (PVX CP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potato virus X coat protein (PVX CP) (PVX CP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call